Compare BIOA & KF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIOA | KF |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.7M | 151.3M |
| IPO Year | 2024 | N/A |
| Metric | BIOA | KF |
|---|---|---|
| Price | $12.47 | $35.44 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.33 | N/A |
| AVG Volume (30 Days) | ★ 410.3K | 18.4K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,917,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.88 | $18.30 |
| 52 Week High | $13.10 | $25.56 |
| Indicator | BIOA | KF |
|---|---|---|
| Relative Strength Index (RSI) | 77.17 | 52.77 |
| Support Level | $12.00 | $35.10 |
| Resistance Level | $13.10 | $36.09 |
| Average True Range (ATR) | 0.72 | 0.51 |
| MACD | 0.26 | -0.01 |
| Stochastic Oscillator | 87.28 | 68.09 |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and Others.